Nava Health Announces New Precision-Driven Longevity Protocols Following Landmark 2026 Menopause Study
United States, 12th Mar 2026 — New clinical findings released in 2026 are reshaping the conversation around hormone health and aging. As growing research highlights the benefits of Bioidentical Hormone Replacement Therapy (BHRT), Nava Health is announcing the expansion of its precision-driven longevity protocols designed to help men and women restore hormonal balance and improve overall health outcomes.
Historically, hormone therapy has faced skepticism due to earlier studies that evaluated synthetic hormone treatments. However, recent data and improved clinical practices are helping to distinguish bioidentical hormone therapy from older hormone replacement models. These updated insights confirm that properly prescribed and medically monitored BHRT can be a safe and effective option for i...